Skip to content

Findings
Treatments
Trials
NMA lab
Protocol
Inventory
Methods
Learn
Data

Home
Treatments
Exengluc iv 25-25ng/min cont

GLP1_NEW

Exengluc iv 25-25ng/min cont

EXENGLUC_IV_25-25NG/MIN_CONT

Trials: 0
Participants in these arms: 0

Related

All doses pooled: Exengluc iv

Trials

LivingGLP1

An independent, living systematic review and network meta-analysis of GLP-1 receptor agonist containing medicines. Not funded by any manufacturer. Not medical advice: talk to a clinician about your own treatment.

Release 2026-10-30

Results

Findings by condition
Treatments
Trials
Effect modifiers
NMA lab

Evidence base

Study inventory
Screening
Full texts
Systematic reviews

Protocol

Protocol
Versions
Amendments
Peer review
Methods

Open science

How to read the results
Glossary
Data and API
About and citation
Source on GitHub

Part of the Xera.ac open science platform. Data and code under open licenses.Blue circle: the International Diabetes Federation symbol for diabetes.